XML 32 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions, Dispositions, and Mortgage Funding
6 Months Ended
Jun. 30, 2013
Acquisitions and Dispositions [Abstract]  
Acquisitions, Dispositions, and Mortgage Funding
Acquisitions, Dispositions and Mortgage Fundings
Real Estate Acquisitions
Second Quarter
In April 2013, the Company purchased a 42,627 square foot inpatient rehabilitation facility in Texas for a purchase price and cash consideration of $16.3 million. The property is 100% leased to one tenant.

First Quarter
In January 2013, the Company purchased a 52,225 square foot medical office building in Tennessee for a purchase price and cash consideration of $16.2 million. The Company recorded approximately $0.5 million of market rate lease intangibles upon acquisition. The property is 100% leased to four tenants and is adjacent to a 39,345 square foot medical office building the Company purchased in October 2012.

The following table details the Company's acquisitions for the six months ended June 30, 2013:

(Dollars in millions)
Date
Acquired
 
Purchase Price
 
Cash
Consideration
 
Real
Estate
 
Other
 
Square
Footage
Real estate acquisitions
 
 
 
 
 
 
 
 
 
 
Tennessee
1/29/13
 
$
16.2

 
$
16.2

 
$
15.7

 
$
0.5

 
52,225

Texas
4/8/13
 
16.3

 
16.3

 
16.3

 

 
42,627

 
 
 
$
32.5

 
$
32.5

 
$
32.0

 
$
0.5

 
94,852



Asset Dispositions
Second Quarter
In April 2013, the Company disposed of a 17,696 square foot medical office building in Tennessee, in which the Company had an aggregate net investment of $0.4 million. The sales price of $0.6 million was funded by the Company under a mortgage note receivable that matures on April 30, 2018 and bears interest at 7.5% per annum. The approximate $0.2 million gain has been deferred and will be recognized as payments on the mortgage note are made under the installment method. The property was not previously classified as held for sale.

In May 2013, the Company disposed of an 8,000 square foot medical office building in Texas, in which the Company had an aggregate net investment of $0.9 million. The sales price was approximately $1.3 million comprised of $1.2 million in net cash proceeds and closing costs of $0.1 million. The Company recognized a $0.3 million gain on the disposal. The property was not previously classified as held for sale.

In May 2013, the Company disposed of a 100,920 square foot medical office building in Texas. The Company had an aggregate net investment of $3.0 million in this property including the effects of a $0.3 million impairment charge recorded in the first quarter of 2013 based on the execution of the sales agreement, a level 2 input. The sales price was approximately $3.2 million comprised of $3.0 million in net cash proceeds and closing costs of $0.2 million. The Company recognized an immaterial gain on the disposal of this property that was previously classified as held for sale.

In June 2013, the Company disposed of a 9,153 square foot medical office building and a 22,572 square foot medical office building, both in Iowa, in which the Company had an aggregate net investment of approximately $5.3 million. The total sales price and cash consideration for the two properties were $6.9 million. In connection with the sales, the Company repaid a mortgage note payable of $1.1 million and incurred debt extinguishment costs of $0.3 million. The Company recognized a $1.5 million aggregate gain on the disposal of the two properties, including the write-off of a straight-line rent receivable of $0.1 million. The properties were not previously classified as held for sale.

First Quarter
In March 2013, the Company disposed of 15.1 acres of land in Texas in which the Company had an aggregate net investment of approximately $8.1 million. The sales price was approximately $5.0 million, which included $1.1 million in net cash proceeds, the origination of a $3.7 million Company-financed mortgage note receivable and closing costs of $0.2 million. The Company-financed mortgage note receivable bears interest of 5.0% in the first year and 6.0% in the second year and matures in March 2015. The Company recognized a $3.3 million impairment on the disposal based on the contractual sales price, a level 1 input. The land parcel was not previously classified as held for sale.

The following table details the Company's dispositions for the six months ended June 30, 2013:

(Dollars in millions)
Date
Disposed
 
Sales Price
 
Closing Adjustments
 
Company-Financed Mortgage
Notes
 
Net
Proceeds
 
Net Real
Estate
Investment
 
Other
(including
receivables)
 
Gain/
(Impairment)
 
Square
Footage
Real estate dispositions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Texas (land)
3/25/2013
 
$
5.0

 
$
(0.2
)
 
$
(3.7
)
 
$
1.1

 
$
8.1

 
$

 
$
(3.3
)
 

Tennessee (1)
4/30/2013
 
0.6

 

 
(0.6
)
 

 
0.4

 

 

 
17,696

Texas
5/15/2013
 
1.3

 
(0.1
)
 

 
1.2

 
0.9

 

 
0.3

 
8,000

Texas (1)
5/24/2013
 
3.2

 
(0.2
)
 

 
3.0

 
3.0

 

 

 
100,920

Iowa (2) (3)
6/3/2013
 
6.9

 

 

 
6.9

 
5.3

 
0.1

 
1.5

 
31,725

Total dispositions
 
$
17.0

 
$
(0.5
)
 
$
(4.3
)
 
$
12.2

 
$
17.7

 
$
0.1

 
$
(1.5
)
 
158,341

(1)
Previously included in assets held for sale.
(2)
Includes two properties.
(3)
Repaid a mortgage note payable upon sale of $1.1 million and incurred debt extinguishment costs of $0.3 million.

Subsequent Dispositions
On July 15, 2013, the Company disposed of an inpatient rehabilitation facility located in Florida that was classified as held for sale and in which the Company had a $7.4 million net investment at June 30, 2013. The base rent was approximately $0.4 million per quarter as of June 30, 2013. The sales price was $11.9 million. This property was sold pursuant to a purchase option contained in the lease which expired on July 15, 2013. The Company expects to record a $4.3 million gain on the disposal.

On July 31, 2013, the Company expects to close on the disposition of an inpatient rehabilitation facility located in Alabama that was classified as held for sale and in which the Company had a $11.2 million net investment at June 30, 2013. The base rent was approximately $0.6 million per quarter as of June 30, 2013. The sales price is $17.5 million. This property will be sold pursuant to a purchase option contained in the lease which expires on July 31, 2013. The Company expects to record a $6.2 million gain on the disposal.

Potential Dispositions
The Company received notice in April 2013 that a tenant is exercising purchase options on two inpatient rehabilitation facilities located in Pennsylvania upon the expiration of the current leases on September 30, 2013. The purchase prices will be the greater of fair market value or $17.6 million for each facility. The Company's aggregate net investment in the two facilities was approximately $24.9 million, and base rent was approximately $1.3 million per quarter as of June 30, 2013. Subsequent to providing notice of its exercise of the purchase options, the operator contacted the Company to continue long-term lease renewal discussions for these two properties. These discussions are on-going as of the date of this report. If the Company does not reach an agreement with the tenant to renew these two leases, the properties are expected to be sold on September 30, 2013 pursuant to the option terms.

Mortgage Note Fundings
During the six months ended June 30, 2013, the Company funded $45.9 million on two outstanding construction mortgage notes for build-to-suit facilities leased to Mercy Health. The total amount outstanding on these facilities in Oklahoma and Missouri is approximately $164.3 million at June 30, 2013. Details on the two projects are as follows:

The Company provided $18.1 million in fundings during the six months ended June 30, 2013 on the medical office building under construction in Oklahoma, bringing cumulative fundings to date to $74.9 million. This project, which was originally scheduled to be completed in July 2013, sustained tornado damage in late May 2013. The tornado damage has caused a delay in the completion date and an assessment is ongoing as to the total scope of the damage and the expected final completion date. While subject to change, the current estimated completion date is the middle of 2014. Builder's risk insurance is expected to fund the necessary repairs. Approximately $16.3 million remains available under the loan.

The Company provided $27.8 million in fundings during the six months ended June 30, 2013 on the orthopedic facility under construction in Missouri, bringing cumulative fundings to date to $89.4 million. This project was scheduled to be completed in November 2013, but is ahead of schedule and is now expected to be completed in September 2013. The Company anticipates funding the remaining $22.0 million under the loan and expects to acquire the facility for the outstanding loan balance during the third quarter of 2013.

Company-Financed Mortgage Notes
During 2013, the Company:

originated a $3.7 million seller-financed mortgage note receivable with the purchaser of the land parcel located in Texas that was sold by the Company as discussed in "Asset Dispositions" above.

originated a $0.6 million seller-financed mortgage note receivable with the purchaser of a medical office building located in Tennessee that was sold by the Company as discussed in "Asset Dispositions" above.

Noncontrolling Interest
In January 2013, the Company received a $1.4 million capital contribution from a 40% noncontrolling interest holder in a partnership that owns a medical office building and parking garage in Texas included as a property in stabilization. The partnership owner (HRP MAC III, LLC), in which the Company holds a 60% majority controlling interest, is the borrower under a term loan from the Company of approximately $10.3 million. These buildings were constructed by the Company and were previously subject to a construction mortgage note totaling $13.7 million. The Company's equity in and loan to the partnership are eliminated in consolidation.

Discontinued Operations and Assets Held for Sale
At June 30, 2013 and December 31, 2012, the Company had two and one properties, respectively, classified as held for sale.
(Dollars in thousands)
June 30, 2013
 
December 31, 2012
Balance Sheet data:
 
 
 
Land
$

 
$
3,835

Buildings, improvements and lease intangibles
29,425

 
5,566

Personal property

 
207


29,425

 
9,608

Accumulated depreciation
(10,780
)
 
(6,303
)
Assets held for sale, net
18,645

 
3,305

Other assets, net (including receivables)
43

 
32

Assets of discontinued operations, net
43

 
32

Assets held for sale and discontinued operations, net
$
18,688

 
$
3,337

 
 
 
 
Accounts payable and accrued liabilities
$
23

 
$
99

Other liabilities
257

 
32

Liabilities of discontinued operations
$
280

 
$
131



 
Three Months Ended June 30,
 
Six Months Ended June 30,
(Dollars in thousands)
2013
 
2012
 
2013
 
2012
Statements of Operations data:
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
Rental income
$
934

 
$
2,179

 
$
1,947

 
$
6,631

Other operating

 
5

 

 
10

 
934

 
2,184

 
1,947

 
6,641

Expenses
 
 
 
 
 
 
 
Property operating
120

 
611

 
458

 
1,741

General and administrative

 

 
1

 
5

Depreciation
25

 
699

 
114

 
1,648

Amortization
7

 
26

 
18

 
51

Bad debt, net of recoveries

 

 

 
(1
)
 
152

 
1,336

 
591

 
3,444

Other Income (Expense)
 
 
 
 
 
 
 
Loss on extinguishment of debt
(270
)
 

 
(270
)
 

Interest expense
(17
)
 
(25
)
 
(41
)
 
(49
)
Interest and other income, net
6

 
49

 
7

 
165

 
(281
)
 
24

 
(304
)
 
116

Discontinued Operations
 
 
 
 
 
 
 
Income from discontinued operations
501

 
872

 
1,052

 
3,313

Impairments

 
(167
)
 
(3,630
)
 
(4,336
)
Gain on sales of real estate properties
1,783

 
3

 
1,783

 
3,431

Income (Loss) from Discontinued Operations
$
2,284

 
$
708

 
$
(795
)
 
$
2,408